1Seif AE, Manno CS, Sheen C, et al. Identifying autoimmune lym- phoproliferative syndrome in children with Evans syndrome: a multi-institutional study. Blood, 2010, 115 : 2142-2145.
2Alvarado CS, Straus SE, Li S, et al. Autoimmune lymphoprolifer- ative syndrome: a cause of chronic splenomegaly, lymphadenopa- thy, and cytopenias in children-report on diagnosis and manage- ment of five patients. Pediatr Blood Cancer, 2004, 43:164-169.
3Straus SE, Jaffe ES, Puck JM, et al. The development of lympho- mas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood, 2001, 98 : 194-200.
4Bleesing JJ, Brown MR, Novicio C, et al. A composite picture of TcR alpha/ beta( + ) CIM ( - )CD8 ( - ) T Cells (alpha/beta- DNTCs) in humans with autoimmune lymphopro|iferative syn- drome. Clin Immunol, 2002, 104: 21-30.
5Mateo V, Menager M, de Saint-Basile G, et al. Perforin-depend- ent apoptosis functionally compensates Fas deficiency in activation- induced cell death of human T lymphocytes. Blood, 2007, 110: 4285-4292.
6Fischer K, Voelkl S, Heymann J,et al. Isolation and characteriza- tion of human antigen-specific TCR alpha beta + CD4 ( - ) CD8 (-) double-negative regulatory T cells. Blood, 2005, 105: 2828-2835.
7Lenardo M J, Oliveira JB, Zheng L, et al. ALPS-ten lessons from an international workshop on a genetic disease of apoptosis. Immu- nity, 2010, 32:291-295.
8Straus SE, Sneller M, Lenardo M J, et al. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syn- drome. Ann Intern Med, 1999, 130:591-601.
9Oliveira JB, Bleesing JJ, Dianzani U, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS) : report from the 2009 NIH International Work- shop. Blood, 2010, 116:e35-ed0.
10Magerus-Chatinet A, Stolzenberg MC, Loffredo MS, et al. FAS- L,IL-10, and double-negative CIM - CD8 - TCR alpha/beta + T cells are reliable markers of autoimmune lymphoproliferative syn- drome (ALPS) associated with FAS loss of function. Blood, 2009, 113:3027-3030.
